These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38926664)

  • 21. Evaluation of neck circumference as an easy and reliable predictor for non-alcoholic fatty liver disease.
    Salmanroghani H; Salmanroghani R; Nourian M; Khayarn K; Lahmi F; Iravani S
    Turk J Gastroenterol; 2019 Feb; 30(2):163-170. PubMed ID: 30541716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
    Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
    Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
    Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of risk factors for non-alcoholic fatty liver disease in hospitalized children with obesity before the late puberty stage.
    Zhou L; Zhang L; Zhang L; Yi W; Yu X; Mei H; Xiao H; Wang Y; Qin H; Xiong X; Yan S; Dong H; Chen P; Chen X
    Front Endocrinol (Lausanne); 2023; 14():1224816. PubMed ID: 37720532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
    Mohamed RZ; Jalaludin MY; Anuar Zaini A
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of neck circumference-related indices with metabolic, atherogenic and liver function biomarkers in patients with non-alcoholic fatty liver disease: a cross-sectional study.
    Arefhosseini S; Tutunchi H; Tavakkoli S; Arefhosseini SR; Ebrahimi-Mameghani M
    BMJ Open; 2023 Sep; 13(9):e073452. PubMed ID: 37699622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical investigation of disparity of nonalcoholic fatty liver disease in a Chinese occupational population in Taipei, Taiwan: experience at a teaching hospital.
    Wang J; Chiu WH; Chen RC; Chen FL; Tung TH
    Asia Pac J Public Health; 2015 Mar; 27(2):NP1793-804. PubMed ID: 23596266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of non alcoholic fatty liver and Non alcoholic Steatohepatitis in Peshawar Cantonment, Khyber Pakhtunkhwa, Pakistan.
    Shah AS; Khan S; Rahim H; Chishti KA; Khan AG
    Pak J Pharm Sci; 2018 Jan; 31(1):193-198. PubMed ID: 29348103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.
    Lee YC; Wu JS; Yang YC; Chang CS; Lu FH; Chang CJ
    Scand J Gastroenterol; 2014 Aug; 49(8):1001-6. PubMed ID: 24989169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan.
    Shen HC; Zhao ZH; Hu YC; Chen YF; Tung TH
    Clin Interv Aging; 2014; 9():501-8. PubMed ID: 24741297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of ultrasound diagnosed nonalcoholic fatty liver disease among rural indigenous community of Sarawak and its association with biochemical and anthropometric measures.
    Cheah WL; Lee PY; Chang CT; Mohamed HJ; Wong SL
    Southeast Asian J Trop Med Public Health; 2013 Mar; 44(2):309-17. PubMed ID: 23691641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease.
    Abangah G; Yousefi A; Asadollahi R; Veisani Y; Rahimifar P; Alizadeh S
    Iran Red Crescent Med J; 2014 Jan; 16(1):e12669. PubMed ID: 24719704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and risk factors of nonalcoholic fatty liver disease in a general population, the HUNT study.
    Bjørnå ER; Engelsen MT; El-Serag HB; Ness-Jensen E
    Scand J Gastroenterol; 2023 May; 58(5):505-511. PubMed ID: 36314512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study.
    Roberts SK; Majeed A; Glenister K; Magliano D; Lubel JS; Bourke L; Simmons D; Kemp WW
    Med J Aust; 2021 Jul; 215(2):77-82. PubMed ID: 34028830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease.
    Abedini R; Salehi M; Lajevardi V; Beygi S
    Clin Exp Dermatol; 2015 Oct; 40(7):722-7. PubMed ID: 25958919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large-scale analysis of factors influencing nonalcoholic fatty liver disease and its relationship with liver enzymes.
    Bi WR; Yang CQ; Shi Q; Xu Y; Cao CP; Ling J; Wang XY
    Genet Mol Res; 2014 Aug; 13(3):5880-91. PubMed ID: 25117346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic Fatty Liver Disease and Associated Risk Factors in Obese Nigerians: A Cross-Sectional Study.
    Onyia CP; Asogwa P; Adiri W; Obienu O; Ijoma UN; Nwokediuko SC; Okeke EN
    Niger J Clin Pract; 2024 Mar; 27(3):352-360. PubMed ID: 38528356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease.
    Qiu J; Kuang M; Yang R; Yu C; He S; Sheng G; Zou Y
    Front Endocrinol (Lausanne); 2023; 14():1239398. PubMed ID: 37727457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
    Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
    World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China.
    Lin S; Xian Y; Liu Y; Cai W; Song J; Zhang X
    Medicine (Baltimore); 2018 Mar; 97(9):e0021. PubMed ID: 29489647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.